Pioneering RNA Therapeutics for Liver Disease
RNA therapeutics represent a transformative approach to treating disease, offering unprecedented precision and speed that conventional small molecule drugs cannot match. This allows us to address previously undruggable targets, modulate specific biological pathways, and respond rapidly to emerging therapeutic needs.
Our Mission
We are committed to transforming the lives of patients with chronic liver disease by developing innovative, targeted RNA medicines that halt and reverse disease progression.
With our differentiated approach and deep expertise in RNA biology and liver metabolism, we aim to establish a new standard of care for liver fibrosis and expand into additional hepatic indications.
Our Technology
Our lead programme leverages novel Target Site Blocker (TSB) technology, creating precisely engineered RNA molecules which enable highly specific delivery to liver cells.
This enables them to selectively modulate gene expression to restore normal function and reverse fibrotic progression by addressing the underlying metabolic dysfunction that drives fibrosis.
This targeted approach dramatically minimises off-target effects while maximizing therapeutic efficacy.
The New Standard in Liver Health:
Our Approach, Our Team, Our Purpose
Contact us
Interested in collaborating with us?
Share your comtact details and we will be in touch shortly.
We can’t wait to hear from you!